These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R J Urol; 2000 Nov; 164(5):1834-7. PubMed ID: 11025779 [TBL] [Abstract][Full Text] [Related]
4. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R J Urol; 2003 Feb; 169(2):701-5. PubMed ID: 12544346 [TBL] [Abstract][Full Text] [Related]
5. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981 [TBL] [Abstract][Full Text] [Related]
6. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568 [TBL] [Abstract][Full Text] [Related]
7. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients]. Cai QQ; Huang HQ; Lin TX; Jiang WQ Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811 [TBL] [Abstract][Full Text] [Related]
8. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Lara O; Tong X; Zborowski M; Chalmers JJ Exp Hematol; 2004 Oct; 32(10):891-904. PubMed ID: 15504544 [TBL] [Abstract][Full Text] [Related]
9. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015 [TBL] [Abstract][Full Text] [Related]
10. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol. Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095 [TBL] [Abstract][Full Text] [Related]
11. Detection of disseminated epithelial cancer cells by liquid culture--factors interfering with the standardization of assays. Krüger WH; Lange A; Badbaran A; Gutensohn K; Kröger N; Zander AR Cytotherapy; 2003; 5(3):252-8. PubMed ID: 12850794 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172 [TBL] [Abstract][Full Text] [Related]
13. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases. Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398 [TBL] [Abstract][Full Text] [Related]
14. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC. Partridge M; Phillips E; Francis R; Li SR J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599 [TBL] [Abstract][Full Text] [Related]
15. Cytokeratin-positive cells in PBSC collections from normal donors and patients with non-epithelial cell-derived tumors. Bills AC; Green WF; Tsodikov A; Carey MJ; Perkins SL; Petersen FB; Beatty PG; Kelley LL Cytotherapy; 1999; 1(5):389-9. PubMed ID: 20440913 [TBL] [Abstract][Full Text] [Related]
16. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry. Takao M; Takeda K Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706 [TBL] [Abstract][Full Text] [Related]
17. Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood. Stimpfl M; Schmid BC; Obermair A; Tong D; Schiebel I; Gitsch G; Leodolter S; Zeillinger R Oncol Res; 1999; 11(8):367-73. PubMed ID: 10803740 [TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study. Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348 [TBL] [Abstract][Full Text] [Related]
19. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting. Wang GY; Li Y; Yu YM; Yu B; Zhang ZY; Liu Y; Wang SJ J Gastroenterol Hepatol; 2009 Feb; 24(2):299-306. PubMed ID: 19032456 [TBL] [Abstract][Full Text] [Related]
20. [Detecting bone marrow micrometastasis of gastric cancer by magnetic activated cell sorting combined with fluorescent activated cell sorting]. Wang GY; Wang SJ; Li Y; Fan LQ; Song ZC; Wang LL; Zhao Q; Jiao ZK; Zhang ZD; Zhao XF; Wang D Ai Zheng; 2005 May; 24(5):605-10. PubMed ID: 15890107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]